Doctor profile · Federal record

Dr. Gina Inthavong, Nurse Practitioner

Nurse Practitioner · Shreveport, LA

  • NPI 1912579301
  • Accepts Medicare
  • MIPS 72.7 / 100 · 2023
  • 5 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
1800 Buckner St Ste C120
Shreveport, LA 711014453
(318) 227-8899
fax (318) 425-3793
Additional location
2501 Greenwood RD
Shreveport, LA 711033905
(318) 631-1584
fax (318) 213-0860

Credentials & registration

NPPES · NUCC
NPI registered
July 2021 — 5 yrs on file
Year of graduation
2021 — 5 yrs since
Specialty taxonomy
363L00000X — NUCC code
State license (1)
Louisiana #221149

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1912579301. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,513
Distinct HCPCS
10
Medicare allowed
$38,513
HCPCS Description Services Patients Avg allowed
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 440 15 $8
99214 Established patient office or other outpatient visit, 30-39 minutes 232 215 $101
36415 Insertion of needle into vein for collection of blood sample 117 105 $5
80069 Kidney function blood test panel 110 100 $9
83735 Magnesium level 110 100 $7
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 92 84 $8
82043 Urine microalbumin (protein) level 89 81 $6
82570 Creatinine level to test for kidney function or muscle injury 88 81 $5
83970 Parathormone (parathyroid hormone) level 56 55 $40
82306 Vitamin d-3 level 51 50 $29

In context: peer comparison

Among 20 peers in Shreveport Nurse Practitioner, average services per provider: 96. This provider delivers 16× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,520
Transactions
176
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 25 $595.35
Fresenius USA Marketing, INC. 21 $389.50
Opko Pharmaceuticals, LLC 26 $369.72
AstraZeneca Pharmaceuticals Lp 11 $339.57
Mallinckrodt Hospital Products INC. 18 $309.20
Calliditas Therapeutics US INC. 18 $290.35
Otsuka America Pharmaceutical, INC. 13 $280.36
Travere Therapeutics, INC. 11 $186.06
Boehringer Ingelheim Pharmaceuticals, INC. 8 $149.82
Novartis Pharmaceuticals Corporation 7 $125.62
GlaxoSmithKline, LLC. 6 $119.15
Akebia Therapeutics INC 3 $85.31
Bayer Healthcare Pharmaceuticals INC. 4 $85.24
Alexion Pharmaceuticals, INC. 3 $45.22
Ani Pharmaceuticals, INC. 2 $38.77

By nature of payment

Food and Beverage
$3,150
Education
$370

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,023
Patients
370
Total drug cost
$176,755
Drug Type Claims Patients Total cost
Calcitriol Generic 289 113 $3,943
Losartan Potassium Generic 126 52 $1,067
Farxiga (Dapagliflozin Propanediol) Brand 85 26 $78,725
Hydralazine Hcl Generic 78 38 $1,710
Amlodipine Besylate Generic 66 26 $215
Cinacalcet Hcl Generic 59 20 $6,594
Lokelma (Sodium Zirconium Cyclosilicate) Brand 49 19 $44,346
Potassium Chloride Generic 46 16 $567
Furosemide Generic 41 23 $162
Nifedipine ER (Nifedipine) Brand 37 19 $940

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Gina Inthavong's medical specialty?
Dr. Gina Inthavong practices Nurse Practitioner in Shreveport, LA.
Where does Dr. Gina Inthavong practice?
Dr. Gina Inthavong practices at 1800 Buckner St Ste C120, Shreveport, LA 711014453. Office phone: 3182278899.
What is Dr. Gina Inthavong's NPI?
Dr. Gina Inthavong's National Provider Identifier (NPI) is 1912579301, issued by NPPES.
Does Dr. Gina Inthavong accept Medicare assignment?
Yes. Dr. Gina Inthavong accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gina Inthavong commonly perform?
Top Medicare-reported procedures in 2023: Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS Q5106); Established patient office or other outpatient visit (HCPCS 99214); Insertion of needle into vein for collection of blood sample (HCPCS 36415). Source: CMS Medicare Physician & Other Practitioners file.